Lupus-Like Immune Complex-Mediated Glomerulonephritis in Patients With Hepatitis C Virus Infection Treated With Oral, Interferon-Free, Direct-Acting Antiviral Therapy
暂无分享,去创建一个
R. Colvin | R. Chung | H. Rennke | D. Mount | R. Thadhani | Jodie L Babitt | R. N. Smith | Andrew L. Lundquist | I. Rosales | M. Sise | N. Hashemi | K. Corapi | W. Williams | J. Holmes | K. Andersson | J. Tangren | D. Chute | Jessica Wisocky | R. Smith | Ravi I. Thadhani | Kristin M. Corapi
[1] J. Trotter,et al. Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[2] K. Reddy,et al. Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection. , 2016, Gastroenterology.
[3] R. Chung,et al. Treatment of hepatitis C virus–associated mixed cryoglobulinemia with direct‐acting antiviral agents , 2016, Hepatology.
[4] S. Pungpapong,et al. Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis , 2015, Hepatology.
[5] P. Messa,et al. Rituximab therapy for primary glomerulonephritis: Report on two cases. , 2015, World journal of clinical cases.
[6] A. Fabbrizzi,et al. Long‐term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open‐label, cohort study , 2015, Hepatology.
[7] R. Chung,et al. Enhancing Our Understanding of Current Therapies for Hepatitis C Virus (HCV) , 2015, Current HIV/AIDS Reports.
[8] D. Roberts,et al. Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease. , 2015, Journal of autoimmunity.
[9] J. Ward,et al. Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 , 2014, Annals of Internal Medicine.
[10] M. Haberal,et al. Clinicopathologic study of kidney biopsies in patients before or after liver transplant. , 2014, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.
[11] W. Koldingsnes,et al. Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre. , 2013, Rheumatology.
[12] T. Tsunoda,et al. Hepatitis C Virus Infection Suppresses the Interferon Response in the Liver of the Human Hepatocyte Chimeric Mouse , 2011, PloS one.
[13] V. D’Agati,et al. Collapsing Focal Segmental Glomerulosclerosis , 2020, Consultant.
[14] A. McLean,et al. Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C. , 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[15] S. Akira,et al. Hepatitis C Virus Nonstructural Protein 5A Modulates the Toll-Like Receptor-MyD88-Dependent Signaling Pathway in Macrophage Cell Lines , 2007, Journal of Virology.
[16] M. Pirisi,et al. Antiviral treatment of hepatitis C , 2006, Expert opinion on pharmacotherapy.
[17] B. Julian,et al. Brief Communication: Glomerulonephritis in Patients with Hepatitis C Cirrhosis Undergoing Liver Transplantation , 2006, Annals of Internal Medicine.
[18] J. Piette,et al. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] G. Mazzucco,et al. Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy. , 2003, Kidney international.
[20] D. Vergani,et al. Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. , 2003, Clinical and experimental immunology.
[21] S. Dikman,et al. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. , 2002, Seminars in arthritis and rheumatism.
[22] J. Feehally,et al. Glomerular IgA deposition in liver disease. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] R. Rodby,et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. , 1993, Journal of the American Society of Nephrology : JASN.
[24] L. Rönnblom,et al. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. , 1991, Annals of internal medicine.
[25] J. Jennette,et al. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. , 1983, Kidney international.